Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
 free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 free
 free
Warning: file_get_contents(http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=19638458&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests
in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 445
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
Starving the addiction: new opportunities for durable suppression of AR signaling in prostate cancer Knudsen KE; Scher HIClin Cancer Res 2009[Aug]; 15 (15): 4792-8Clinical data and models of human disease indicate that androgen receptor (AR) activity is essential for prostate cancer development, growth, and progression. The dependence of prostatic adenocarcinoma on AR signaling at all stages of disease has thereby been exploited in the treatment of disseminated tumors, for which ablation of AR function is the goal of first-line therapy. Although these strategies are initially effective, recurrent tumors arise with restored AR activity, and no durable treatment has yet been identified to combat this stage of disease. New insights into AR regulation and the mechanisms underlying resurgent AR activity have provided fertile ground for the development of novel strategies to more effectively inhibit receptor activity and prolong the transition to therapeutic failure.|Androgen Antagonists/therapeutic use[MESH]|Androgen Receptor Antagonists[MESH]|Androgens/metabolism[MESH]|Anilides/therapeutic use[MESH]|Flutamide/therapeutic use[MESH]|Humans[MESH]|Male[MESH]|Nitriles/therapeutic use[MESH]|Prostatic Neoplasms/*drug therapy/metabolism[MESH]|Protein Structure, Tertiary/physiology[MESH]|Receptors, Androgen/*metabolism[MESH]|Signal Transduction/drug effects/physiology[MESH]|Tosyl Compounds/therapeutic use[MESH] |
